Vaxil Biotherapeutics is developing a revolutionary new treatment for cancer called ImMucin.

ImMucin is a new type of drug called a therapeutic vaccine. A therapeutic vaccine harnesses the power of the body's immune system to fight cancer.

A therapeutic vaccine teaches the body's immune system...

Lior Carmon, Vaxil Biotherapeutics Ltd., Nes-Ziona, Israel
Phase I/II study of Immucin, a pan-HLA, anti-MUC1 signal peptide vaccine in MM patients with residual disease or progression following autologous stem cell transplant.